In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 79 for your search:
Drug:  ixabepilone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA163-046, NCT00080301
2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA163-048, NCT00082433
3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Tissue collection/Repository, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: PACS08 - UC-0140/0610, PACS-08/0610, 2006-006494-24, PACS08-Tavlx, BMS-UNICANCER-PACS-08/0610, AMGEN-UNICANCER-PACS-08/0610, FNCLCC-PACS-08/0610, FNCLCC-PACS 08/0610 – TavIx, EU-20804, FNCLCC-Tavlx, BMS-FNCLCC-PACS-08/0610, AMGEN-FNCLCC-PACS-08/0610, NCT00630032
4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00476, CALGB 40502, U10CA031946, NCT00785291
5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI BRE 145, TITAN, NCT00789581
6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA163-196, 2008-007167-16, NCT00883116
7.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RC08CC, NCI-2009-01229, 08-008811, CA163-195, NCT00998738
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-01064, MSKCC-01064A, NCI-3634, NCT00025194, 3634
9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03016, NABTT 2111, CDR257118, U01CA062475, JHOC-NABTT-2111, NCT00045708
10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02523, UPCC-04302, NCI-5787, CDR0000276716, 5787, NCT00057850
11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000393439, AECM-03099, AECM-CA163402, AECM-NMC-03-10-277C, NCT00096317
12.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00140, 0504007857, CDR0000441122, N01CM62204, AECM-0504007857, NCI-7229, 7229, NCT00182767
13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00155, 055513, CDR0000481121, N01CM62202, UCSF-055513, NCI-7347, 7347, NCT00331344
14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI BRE 138, NCT00825734
15.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ALSSMBC0804, NCT00924352
16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S0111, S0111, NCT00016393
17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-S0107, S0107, NCT00016965
18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000068644, BMS-MSKCC-01011, MSKCC-01011, NCI-G01-1949, NCT00017043
19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-01015, NCI-G01-1950, NCT00017056
20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01031, BMS-CA163-009, CPMC-IRB-13916, NCI-G01-1967, NCT00020904
21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02390, E3800, U10CA021115, CDR0000068747, ECOG-E3800, NCT00021099
22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11003B, UCCRC-11003B, NCI-3670, 3670, NCT00022477
23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02413, GOG-0126M, U10CA027469, CDR0000068927, NCT00025155
24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000069190, AECM-3632, MCC-12602, NCI-3632, 3632, NCT00030706
25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069272, UAB-0145, BMS-CA163-012, UAB-F011029021, NCI-G02-2051, NCT00033306
1     
New Search